Intellipharmaceutics International Inc (IPCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPCIF | ZTS | TAK | NBIX | UTHR |
| Company | Intellipharmaceutics International Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.0750 | 152.63 | 13.08 | 137.47 | 236.59 |
| High | 0.0750 | 158.74 | 13.08 | 138.63 | 237.53 |
| Low | 0.0600 | 152.63 | 13.01 | 135.17 | 233.64 |
| Last | 0.0600 | 158.42 | 13.03 | 135.99 | 233.85 |
| Change | unch | +5.06 | -0.04 | -1.77 | -2.10 |
| % Change | unch | +3.30% | -0.31% | -1.28% | -0.89% |
| Volume | 7,500 | 5,236,400 | 1,213,400 | 717,500 | 369,600 |
| 20-Day Average Volume | 10,000 | 4,280,780 | 1,749,100 | 765,780 | 491,470 |
| Previous Close | 0.0600 | 153.36 | 13.07 | 137.76 | 235.95 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0705 | 157.36 | 13.39 | 136.46 | 234.48 |
| 20-Day Raw Stochastic | 29.91% | 55.16% | 3.23% | 39.41% | 62.10% |
| 20-Day Relative Strength | 49.21% | 43.71% | 33.29% | 49.27% | 49.91% |
| Weighted Alpha | -60.43 | -14.57 | -22.33 | +35.60 | +3.13 |
| Today's Opinion | 16% Sell | 72% Sell | 100% Sell | 48% Buy | 64% Buy |
| Previous Opinion | 16% Sell | 88% Sell | 100% Sell | 96% Buy | 80% Buy |
| Last Month's Opinion | 88% Sell | 40% Sell | 72% Sell | 88% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.29% since 04/18/24 | +8.14% since 04/19/24 | -1.59% since 04/19/24 | +3.02% since 04/19/24 | -1.71% since 04/19/24 |
| Low | 0.0600 on 04/26/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 131.79 on 04/22/24 | 233.27 on 04/24/24 |
| High | 0.1200 on 04/22/24 | 158.74 on 04/26/24 | 13.41 on 04/23/24 | 145.00 on 04/23/24 | 241.00 on 04/24/24 |
| 1-Month | |||||
| %Chg | -25.00% since 03/26/24 | -4.38% since 03/26/24 | -9.45% since 03/26/24 | -3.66% since 03/26/24 | -5.65% since 03/26/24 |
| Low | 0.0600 on 04/26/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 130.13 on 04/19/24 | 221.53 on 04/01/24 |
| High | 0.1350 on 04/16/24 | 171.14 on 03/28/24 | 14.37 on 03/27/24 | 145.00 on 04/23/24 | 249.68 on 03/27/24 |
| 3-Month | |||||
| %Chg | unch since 01/26/24 | -17.28% since 01/26/24 | -10.75% since 01/26/24 | -4.33% since 01/26/24 | +7.27% since 01/26/24 |
| Low | 0.0255 on 03/14/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 128.00 on 02/07/24 | 208.62 on 02/08/24 |
| High | 0.1350 on 04/16/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 148.37 on 03/21/24 | 250.89 on 03/26/24 |
| 6-Month | |||||
| %Chg | unch since 10/24/23 | +0.22% since 10/26/23 | -2.62% since 10/26/23 | +26.01% since 10/26/23 | +4.21% since 10/26/23 |
| Low | 0.0255 on 03/14/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 103.63 on 11/10/23 | 208.62 on 02/08/24 |
| High | 0.1350 on 04/16/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 148.37 on 03/21/24 | 258.31 on 12/14/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,986 | 72,454,816 | 41,237,580 | 13,531,958 | 11,004,745 |
| Shares Outstanding, K | 33,093 | 457,359 | 3,164,818 | 99,507 | 47,059 |
| Annual Sales | 70,000 | 8,544,000,000 | 29,803,340,000 | 1,887,100,000 | 2,327,500,000 |
| Annual Net Income | -2,890,000 | 2,344,000,000 | 2,345,930,000 | 249,700,000 | 984,800,000 |
| Last Quarter Sales | 70,000 | 2,213,000,000 | 7,556,070,000 | 515,200,000 | 614,700,000 |
| Last Quarter Net Income | -1,890,000 | 525,000,000 | 718,900,000 | 147,700,000 | 217,100,000 |
| 60-Month Beta | 1.07 | 0.85 | 0.53 | 0.25 | 0.52 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 10/16/23 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 1.44 on 02/07/24 | 4.36 on 02/21/24 |
| Latest Earnings Date | 06/04/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.83 | 6.70 | 56.93 | 11.89 |